Updated June 30 at 9:19pm
Life Sciences
15 results total, viewing 1 - 10
More than $480,000 has been awarded by the Rhode Island Foundation in seed funding for 20 medical research projects. more
Alexion Pharmaceuticals Inc. fell the most in six years after the company’s drug for a rare neuromuscular disease failed to meet its primary goal in a final-stage trial. more
Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to maintaining growth. more
A national consultant has advised the I-195 Redevelopment District Commission to create a business innovation district in Providence that is larger than the existing footprint of undeveloped land, and to create an advisory council that would include the perspectives of anchor industries and universities. more
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
Six Rhode Island companies have received state matching grants to leverage federal funds intended to promote innovation in technology. more
An independent analysis of promising economic clusters for Providence to nurture has identified five stars: life sciences, food processing and packaging, social enterprise, design coupled with advanced manufacturing, and education technology. more
Gov. Gina M. Raimondo and Commerce Secretary Stefan Pryor launched three new incentive programs on Wednesday in an effort to grow the state’s economy. more
The U.S. Centers for Disease Control and Prevention has awarded $2 million over four years to a team of University of Rhode Island and University of North Caroline researchers to study Lyme disease prevention and exposure among outdoor workers. more
1 | 2 Next »